122
Views
49
CrossRef citations to date
0
Altmetric
Review

Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus

&
Pages 1239-1255 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fu-Shi Quan, Swarnendu Basak, Ki-Back Chu, Sung Soo Kim & Sang-Moo Kang. (2020) Progress in the development of virus-like particle vaccines against respiratory viruses. Expert Review of Vaccines 19:1, pages 11-24.
Read now
Terianne M. Wong, Nikolai Petrovsky, Stephanie J. Bissel, Clayton A. Wiley & Ted M. Ross. (2016) Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Human Vaccines & Immunotherapeutics 12:8, pages 2096-2105.
Read now

Articles from other publishers (47)

Beate Schmoele-ThomaAgnieszka M. ZarebaQin JiangMohan S. MaddurRana DanafAlex MannKingsley EzeJuin Fok-SeangGolam KabirAndrew CatchpoleDaniel A. ScottAlejandra C. GurtmanKathrin U. JansenWilliam C. GruberPhilip R. DormitzerKena A. Swanson. (2022) Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. New England Journal of Medicine 386:25, pages 2377-2386.
Crossref
Sucheta D’Sa, Kimberly Braz Gomes, Grace Lovia Allotey-Babington, Cemil Boyoglu, Sang-Moo Kang & Martin J. D’Souza. (2022) Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity. Vaccines 10:4, pages 584.
Crossref
Naoko Iwata-Yoshikawa, Nozomi Shiwa, Tsuyoshi Sekizuka, Kaori Sano, Akira AinaiTakuya HemmiMichiyo KataokaMakoto Kuroda, Hideki HasegawaTadaki Suzuki & Noriyo Nagata. (2022) A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection. Science Advances 8:1.
Crossref
Marieke van der Heiden & Debbie van Baarle. 2022. Healthy Longevity and Immune System. Healthy Longevity and Immune System 91 117 .
J. S. Oxford, A. Catchpole, A. Mann, A. Bell, N. Noulin, D. Gill, J. R. Oxford, A. Gilbert & Shobana Balasingam. 2022.
Hye Suk Hwang, Young-Tae Lee, Ki-Hye Kim, Ho Seong Seo, Kap Seung Yang, Hoonsung Cho & Sang-Moo Kang. (2021) Roles of the Fc Receptor γ-Chain in Inducing Protective Immune Responses after Heterologous Vaccination against Respiratory Syncytial Virus Infection. Vaccines 9:3, pages 232.
Crossref
Hanako Sekimukai, Naoko Iwata‐Yoshikawa, Shuetsu Fukushi, Hideki Tani, Michiyo Kataoka, Tadaki Suzuki, Hideki Hasegawa, Kenichi Niikura, Katsuhiko Arai & Noriyo Nagata. (2019) Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiology and Immunology 64:1, pages 33-51.
Crossref
Youri Lee, Eun-Ju Ko, Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, Yu-Jin Jung, Subbiah Jeeva, Young-Man Kwon, Baik Lin Seong & Sang Moo Kang. (2019) The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants. Antiviral Research 168, pages 100-108.
Crossref
Yoshiaki Yamaji, Akihito Sawada, Yosuke Yasui, Takashi Ito & Tetsuo Nakayama. (2019) Simultaneous Administration of Recombinant Measles Viruses Expressing Respiratory Syncytial Virus Fusion (F) and Nucleo (N) Proteins Induced Humoral and Cellular Immune Responses in Cotton Rats. Vaccines 7:1, pages 27.
Crossref
Young-Man KwonHye Suk HwangYoung-Tae LeeKi-Hye KimYouri LeeMin-Chul KimYu-Na LeeFu-Shi QuanMartin L. MooreSang-Moo Kang. (2019) Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform. Immune Network 19:3.
Crossref
Meredith C. Rogers, Kristina D. Lamens, Nazly Shafagati, Monika Johnson, Tim D. Oury, Sebastian Joyce & John V. Williams. (2018) CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses. The Journal of Immunology 201:4, pages 1253-1266.
Crossref
Prasad S. KulkarniJulia L. HurwitzEric A.F. SimõesPedro A. Piedra. (2018) Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field. Viral Immunology 31:2, pages 195-203.
Crossref
Hye Suk Hwang, Young-Tae Lee, Ki-Hye Kim, Eun-Ju Ko, Youri Lee, Young-Man Kwon & Sang-Moo Kang. (2017) Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus. Virology 511, pages 142-151.
Crossref
Nicolás Gálvez, Jorge Soto & Alexis Kalergis. (2017) New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. International Journal of Molecular Sciences 18:8, pages 1753.
Crossref
Abhijeet Bakre, Jennifer Harcourt, Lia Haynes, Larry Anderson & Ralph Tripp. (2017) The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection. Vaccines 5:3, pages 16.
Crossref
Corinne Cayatte, Alexander Marin, Gaurav Manohar Rajani, Kirsten Schneider-Ohrum, Angie Snell Bennett, Jason D. Marshall & Alexander K. Andrianov. (2017) PCPP-Adjuvanted Respiratory Syncytial Virus (RSV) sF Subunit Vaccine: Self-Assembled Supramolecular Complexes Enable Enhanced Immunogenicity and Protection. Molecular Pharmaceutics 14:7, pages 2285-2293.
Crossref
Ran Jia, Lu Lu, Xiaozhen Liang, Zhiwu Sun, Lingbing Tan, Menghua Xu, Liyun Su & Jin Xu. (2017) Poly(U) and CpG ameliorate the unbalanced T cell immunity and pneumonia of mice with RSV vaccine-enhanced disease. BioScience Trends 11:4, pages 450-459.
Crossref
Daniel BurbullaPatrick S. GüntherJanet K. PeperGerhard JahnKevin M. Dennehy. (2016) Human CD8 + T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase . Viral Immunology 29:5, pages 307-314.
Crossref
Stephanie S. Cush, Glennys V. Reynoso, Olena Kamenyeva, Jack R. Bennink, Jonathan W. Yewdell & Heather D. Hickman. (2016) Locally Produced IL-10 Limits Cutaneous Vaccinia Virus Spread. PLOS Pathogens 12:3, pages e1005493.
Crossref
Hsiao-Yun Shao, Juo-Yu Huang, Yi-Wen Lin, Shu-Ling Yu, Ebenezer Chitra, Ching-Kun Chang, Wang-Chou Sung, Pele Chong & Yen-Hung Chow. (2015) Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection. International Journal of Infectious Diseases 41, pages 56-64.
Crossref
Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, Young-Man Kwon, Min-Chul Kim, Eun-Ju Ko, Jong Seok Lee, Youri Lee & Sang-Moo Kang. (2015) Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells. Journal of Virology 89:22, pages 11692-11705.
Crossref
Young-Tae Lee, Ki-Hye Kim, Hye Suk Hwang, Youri Lee, Young-Man Kwon, Eun-Ju Ko, Yu-Jin Jung, Yu-Na Lee, Min-Chul Kim & Sang-Moo Kang. (2015) Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection. Virology 485, pages 36-46.
Crossref
Kathryn Patton, Shahin Aslam, Cindy Shambaugh, Rui Lin, Darren Heeke, Chris Frantz, Fengrong Zuo, Mark T. Esser, Xavier Paliard & Stacie L. Lambert. (2015) Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques. Vaccine 33:36, pages 4472-4478.
Crossref
Stacie L. Lambert, Shahin Aslam, Elizabeth Stillman, Mia MacPhail, Christine Nelson, Bodrey Ro, Rosemary Sweetwood, Yuk Man Lei, Jennifer C. Woo & Roderick S. Tang. (2015) A Novel Respiratory Syncytial Virus (RSV) F Subunit Vaccine Adjuvanted with GLA-SE Elicits Robust Protective TH1-Type Humoral and Cellular Immunity In Rodent Models. PLOS ONE 10:3, pages e0119509.
Crossref
Young-In Kim, John P. DeVincenzo, Bart G. Jones, Rajeev Rudraraju, Lisa Harrison, Rachel Meyers, Jeff Cehelsky, Rene Alvarez & Julia L. Hurwitz. (2014) Respiratory Syncytial Virus Human Experimental Infection Model: Provenance, Production, and Sequence of Low-Passaged Memphis-37 Challenge Virus. PLoS ONE 9:11, pages e113100.
Crossref
Roberto S. Gomez, Isabelle Guisle-Marsollier, Karen Bohmwald, Susan M. Bueno & Alexis M. Kalergis. (2014) Respiratory Syncytial Virus: Pathology, therapeutic drugs and prophylaxis. Immunology Letters 162:1, pages 237-247.
Crossref
Jong Seok Lee, Young-Man Kwon, Hye Suk Hwang, Yu-Na Lee, Eun-Ju Ko, Si-Eun Yoo, Min-Chul Kim, Ki-Hye Kim, Min Kyoung Cho, Young-Tae Lee, You Ri Lee, Fu-Shi Quan & Sang-Moo Kang. (2014) Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus. Vaccine 32:44, pages 5866-5874.
Crossref
Naoko Iwata-Yoshikawa, Akihiko Uda, Tadaki Suzuki, Yasuko Tsunetsugu-Yokota, Yuko Sato, Shigeru Morikawa, Masato Tashiro, Tetsutaro Sata, Hideki Hasegawa & Noriyo Nagata. (2014) Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine. Journal of Virology 88:15, pages 8597-8614.
Crossref
Kathryn Patton, Shahin Aslam, Jim Lin, Li Yu, Stacie Lambert, Glenn Dawes, Mark T. Esser, Jennifer Woo, Sylvia Janetzki & Anu Cherukuri. (2014) Enzyme-Linked Immunospot Assay for Detection of Human Respiratory Syncytial Virus F Protein-Specific Gamma Interferon-Producing T Cells. Clinical and Vaccine Immunology 21:5, pages 628-635.
Crossref
Yae-Jean Kim, Katherine A. Guthrie, Alpana Waghmare, Edward E. Walsh, Ann R. Falsey, Jane Kuypers, Anne Cent, Janet A. Englund & Michael Boeckh. (2014) Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Factors Determining Progression to Lower Respiratory Tract Disease. The Journal of Infectious Diseases 209:8, pages 1195-1204.
Crossref
Ross B. Fulton, Kayla A. Weiss, Lecia L. Pewe, John T. Harty & Steven M. Varga. (2013) Aged Mice Exhibit a Severely Diminished CD8 T Cell Response following Respiratory Syncytial Virus Infection. Journal of Virology 87:23, pages 12694-12700.
Crossref
Patricia A. Jorquera, Youngjoo Choi, Katie E. Oakley, Thomas J. Powell, James G. Boyd, Naveen Palath, Lia M. Haynes, Larry J. Anderson & Ralph A. Tripp. (2013) Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease. PLoS ONE 8:9, pages e74905.
Crossref
Larry J. Anderson. (2013) Respiratory syncytial virus vaccine development. Seminars in Immunology 25:2, pages 160-171.
Crossref
Anu Cherukuri, Kathryn Patton, Robert A. GasserJr.Jr., Fengrong Zuo, Jennifer Woo, Mark T. Esser & Roderick S. Tang. (2013) Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein. Clinical and Vaccine Immunology 20:2, pages 239-247.
Crossref
Marcel A. Schijf, Debby Kruijsen, Jacqueline Bastiaans, Frank E. J. Coenjaerts, Johan Garssen, Grada M. van Bleek & Belinda van't Land. (2012) Specific Dietary Oligosaccharides Increase Th1 Responses in a Mouse Respiratory Syncytial Virus Infection Model. Journal of Virology 86:21, pages 11472-11482.
Crossref
Sheetal A. Thakur, Zachary B. Zalinger, Teresa R. Johnson & Farhad Imani. (2011) Protein Kinase R Is a Novel Mediator of CD40 Signaling and Plays a Critical Role in Modulating Immunoglobulin Expression during Respiratory Syncytial Virus Infection. Clinical and Vaccine Immunology 18:12, pages 2060-2066.
Crossref
Fu-Shi Quan, Yonghwan Kim, Sujin Lee, Hong Yi, Sang-Moo Kang, Jadranka Bozja, Martin L. Moore & Richard W. Compans. (2011) Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice. The Journal of Infectious Diseases 204:7, pages 987-995.
Crossref
Hsiao-Yun Shao, Yi-Wen Lin, Shu-Ling Yu, Hsiang-Yin Lin, Ebenezer Chitra, Yung-Chen Chang, Charles Sia, Pele Chong, Ming-Tao Hsu, Olivia L. Wei & Yen-Hung Chow. (2011) Immunoprotectivity of HLA-A2 CTL Peptides Derived from Respiratory Syncytial Virus Fusion Protein in HLA-A2 Transgenic Mouse. PLoS ONE 6:9, pages e25500.
Crossref
Maria Grazia Cusi, Barbara Martorelli, Giuseppa Di Genova, Chiara Terrosi, Giuseppe Campoccia & Pierpaolo Correale. (2010) Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects. Immunity & Ageing 7:1.
Crossref
Paul J. Jannetto, Blake W. Buchan, Kimberly A. Vaughan, Joellen S. Ledford, Dennis K. Anderson, Donald C. Henley, Neil B. Quigley & Nathan A. Ledeboer. (2010) Real-Time Detection of Influenza A, Influenza B, and Respiratory Syncytial Virus A and B in Respiratory Specimens by Use of Nanoparticle Probes. Journal of Clinical Microbiology 48:11, pages 3997-4002.
Crossref
Terianne Wong, Gary Hellermann & Shyam Mohapatra. (2010) The Infectious March: The Complex Interaction Between Microbes and the Immune System in Asthma. Immunology and Allergy Clinics of North America 30:4, pages 453-480.
Crossref
Ross B. Fulton, David K. Meyerholz & Steven M. Varga. (2010) Foxp3+ CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection. The Journal of Immunology 185:4, pages 2382-2392.
Crossref
Wenliang Zhang, Youngjoo Choi, Lia M. Haynes, Jennifer L. Harcourt, Larry J. Anderson, Les P. Jones & Ralph A. Tripp. (2010) Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice. Journal of Virology 84:2, pages 1148-1157.
Crossref
Alexander A. Rumyantsev, Zhen-xi Zhang, Qing-sheng Gao, Nicolas Moretti, Nathan Brown, Harold Kleanthous, Simon Delagrave, Farshad Guirakhoo, Marc S. Collett & Konstantin V. Pugachev. (2010) Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Virology 396:2, pages 329-338.
Crossref
Ross B FultonSteven M Varga. (2009) Effects of aging on the adaptive immune response to respiratory virus infections. Aging Health 5:6, pages 775-787.
Crossref
C. TERROSI, G. Di GENOVA, B. MARTORELLI, M. VALENTINI & M. G. CUSI. (2009) Humoral immunity to respiratory syncytial virus in young and elderly adults. Epidemiology and Infection 137:12, pages 1684-1686.
Crossref
Helene F. Rosenberg, Kimberly D. Dyer & Joseph B. Domachowske. (2009) Respiratory viruses and eosinophils: Exploring the connections. Antiviral Research 83:1, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.